Efficacy of low-dose radioablation therapy using 740 MBq of I131 in postoperative differentiated thyroid cancer patients. An Initial Experience

被引：0
|
作者：
Iordanidou, L. [1 ]
Papadouli, D. [1 ]
Sevaslidou, I. [1 ]
Trekla, S. [1 ]
Erifillidou, M. [1 ]
Pateniotis, K. [1 ]
Trivizaki, E. [1 ]
机构：
[1] Metaxa Canc Hosp, Piraeus, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0460
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [21] Adjuvant radioactive iodine (I131) therapy in patients with papillary thyroid cancer: comparison of ablation outcome post low and high doses of I131
    Yassin, S. W.
    Salman, K.
    Al-Munshy, T.
    Al-Ezzi, M.
    Salem, S.
    Mohammad, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S398 - S399
  • [22] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [23] Does I-131 uptake in the subhyoid portion or lymph nodes affect the outcome of low-dose ablation therapy for patients with differentiated thyroid cancer?
    Ito, S.
    Iwano, S.
    Kato, K.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S662 - S663
  • [24] Evaluation of quality of life related to the impact of I131 therapy in patients with well-differentiated thyroid cancer in infancy
    Rocha, E. T.
    Correa, L. G.
    Moriguchi, S. M.
    Carvalho, A. L.
    Boldrini, E.
    Silva, E. T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S430 - S430
  • [25] Clinical outcomes of low-dose and high-dose postoperative radioiodine therapy in patients with intermediate-risk differentiated thyroid cancer
    Jeong, Ju Hye
    Kong, Eun Jung
    Jeong, Shin Young
    Lee, Sang-Woo
    Cho, Ihn Ho
    Chun, Kyung Ah
    Lee, Jaetae
    Ahn, Byeong-Cheol
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 228 - 233
  • [26] The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy
    van Dijk, D.
    Plukker, J. T. M.
    van der Horst-Schrivers, A. N. A.
    Jansen, L.
    Brouwers, A. H.
    Muller-Kobold, A.
    Sluiter, W. J.
    Links, T. P.
    CLINICAL ENDOCRINOLOGY, 2011, 74 (01) : 104 - 110
  • [27] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [28] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [29] I-131 ablation therapy in patients with differentiated thyroid cancer: efficacy of different therapeutic protocols
    Salvatori, M
    Rufini, V
    Leccisotti, L
    Perotti, G
    Maussier, ML
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S465 - S465
  • [30] Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer
    Ceccarelli, C
    Battisti, P
    Gasperi, M
    Fantuzzi, E
    Pacini, F
    Gualdrini, G
    Pierantoni, MC
    Luciani, A
    Djokich, D
    Pinchera, A
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (10) : 1716 - 1721
12345